Optimizing insulin secretagogue therapy in patients with type 2 diabetes: a randomized double-blind study with repaglinide (Q43869410)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 2002
edit
Language Label Description Also known as
English
Optimizing insulin secretagogue therapy in patients with type 2 diabetes: a randomized double-blind study with repaglinide
scientific article published in February 2002

    Statements

    Optimizing insulin secretagogue therapy in patients with type 2 diabetes: a randomized double-blind study with repaglinide (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit